GlaxoSmithKline Ditches Ionis Pharma’s Inotersen and IONIS-FB-LRx


Carlsbad, Calif.-based Ionis Pharmaceuticals announced that GlaxoSmithKline declined its options on both inotersen and IONIS-FB-Lrx, which gives Ionis back control of those rights.
Source link